• Je něco špatně v tomto záznamu ?

Plasma cortisol in Alzheimer's disease with or without depressive symptoms

M. Zvěřová, Z. Fišar, R. Jirák, E. Kitzlerová, J. Hroudová, J. Raboch,

. 2013 ; 19 (-) : 681-9.

Jazyk angličtina Země Spojené státy americké

Typ dokumentu časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc14040638

BACKGROUND: Cortisol is presumed to be a risk factor for stress- and age-related disorders, such as depressive disorder and Alzheimer's disease (AD). The aim of this study was to investigate the association of plasma cortisol concentration with AD in presence or absence of comorbid depressive symptoms. MATERIAL AND METHODS: Plasma cortisol concentration was measured in 80 AD patients (35 of them with depressive symptoms), 27 elderly depressive patients without AD, and 37 elderly controls. RESULTS: Compared to controls, a significant increase of mean plasma cortisol was found in AD patients but not in depressive patients. Plasma cortisol was positively correlated with cognitive impairment in AD patients. We confirmed a U-shaped association between plasma cortisol and major depression and a linear association between plasma cortisol and AD without depressive symptoms. Significantly increased relative risk of disease in people with high plasma cortisol was found for AD with depressive symptoms and for AD with mild dementia. CONCLUSIONS: Plasma cortisol reflects the degree of cognitive impairment in AD rather than the severity of comorbid depression. We confirmed that both hypercortisolemia and hypocortisolemia are associated with depressive disorder. Significant association between high plasma cortisol and AD was found, supporting the use of high plasma cortisol as a component of a panel of biochemical markers for AD with depressive symptoms as well as AD in the early stage of dementia development.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc14040638
003      
CZ-PrNML
005      
20171114090607.0
007      
ta
008      
140107s2013 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.12659/MSM.889110 $2 doi
035    __
$a (PubMed)23955525
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Zvěřová, Martina $7 ola2017969594
245    10
$a Plasma cortisol in Alzheimer's disease with or without depressive symptoms / $c M. Zvěřová, Z. Fišar, R. Jirák, E. Kitzlerová, J. Hroudová, J. Raboch,
520    9_
$a BACKGROUND: Cortisol is presumed to be a risk factor for stress- and age-related disorders, such as depressive disorder and Alzheimer's disease (AD). The aim of this study was to investigate the association of plasma cortisol concentration with AD in presence or absence of comorbid depressive symptoms. MATERIAL AND METHODS: Plasma cortisol concentration was measured in 80 AD patients (35 of them with depressive symptoms), 27 elderly depressive patients without AD, and 37 elderly controls. RESULTS: Compared to controls, a significant increase of mean plasma cortisol was found in AD patients but not in depressive patients. Plasma cortisol was positively correlated with cognitive impairment in AD patients. We confirmed a U-shaped association between plasma cortisol and major depression and a linear association between plasma cortisol and AD without depressive symptoms. Significantly increased relative risk of disease in people with high plasma cortisol was found for AD with depressive symptoms and for AD with mild dementia. CONCLUSIONS: Plasma cortisol reflects the degree of cognitive impairment in AD rather than the severity of comorbid depression. We confirmed that both hypercortisolemia and hypocortisolemia are associated with depressive disorder. Significant association between high plasma cortisol and AD was found, supporting the use of high plasma cortisol as a component of a panel of biochemical markers for AD with depressive symptoms as well as AD in the early stage of dementia development.
650    _2
$a senioři $7 D000368
650    _2
$a senioři nad 80 let $7 D000369
650    _2
$a Alzheimerova nemoc $x krev $x komplikace $7 D000544
650    _2
$a demence $x krev $x komplikace $7 D003704
650    _2
$a demografie $7 D003710
650    _2
$a deprese $x krev $x komplikace $7 D003863
650    _2
$a lidé $7 D006801
650    _2
$a hydrokortison $x krev $7 D006854
650    _2
$a lineární modely $7 D016014
650    _2
$a lidé středního věku $7 D008875
650    _2
$a neuropsychologické testy $7 D009483
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Fišar, Zdeněk $u -
700    1_
$a Jirák, Roman $u -
700    1_
$a Kitzlerová, Eva $u -
700    1_
$a Hroudová, Jana $u -
700    1_
$a Raboch, Jiří $u -
773    0_
$w MED00003251 $t Medical science monitor international medical journal of experimental and clinical research $x 1643-3750 $g Roč. 19, č. - (2013), s. 681-9
856    41
$u https://pubmed.ncbi.nlm.nih.gov/23955525 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20140107 $b ABA008
991    __
$a 20171114090716 $b ABA008
999    __
$a ok $b bmc $g 1005034 $s 839150
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2013 $b 19 $c - $d 681-9 $i 1643-3750 $m Medical Science Monitor $n Med Sci Monit $x MED00003251
LZP    __
$a Pubmed-20140107

Najít záznam

Citační ukazatele

Nahrávání dat ...

    Možnosti archivace